BDX Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Becton, Dickinson and Company (NYSE: BDX)
›
Becton, Dickinson and Company (NYSE: BDX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 60,000 employees.
The shares were at 212.73 USD on 19 November 2026, up 41.8% over 52 weeks. Its 52-week range is 140.11 USD to 220.35 USD: the price is 3.5% below the high and 51.8% above the low.
At a market capitalisation of 57.93B USD, it trades at 42.0 times trailing earnings and 15.0 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, a discount of 19% for BDX. It pays a dividend yielding 1.96% (it pays out 72% of its earnings), against a median of 0.71% among the dividend payers in that peer group.
Becton, Dickinson and Company reports return on equity of 6.6%, an operating margin of 15.7% and revenue down 10.5% year over year.
Its debt exceeds its cash by 15.61B USD, a debt-to-equity ratio of 0.76. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 226.14 USD is 6.3% above the current price. The next earnings report is expected on 9 February 2027.